FR2139M - - Google Patents
Download PDFInfo
- Publication number
- FR2139M FR2139M FR901889A FR901889A FR2139M FR 2139 M FR2139 M FR 2139M FR 901889 A FR901889 A FR 901889A FR 901889 A FR901889 A FR 901889A FR 2139 M FR2139 M FR 2139M
- Authority
- FR
- France
- Prior art keywords
- hemostatic
- preparations
- peanuts
- peel
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR901889A FR2139M (enrdf_load_html_response) | 1962-06-25 | 1962-06-25 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR901889A FR2139M (enrdf_load_html_response) | 1962-06-25 | 1962-06-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2139M true FR2139M (enrdf_load_html_response) | 1963-12-13 |
Family
ID=27589491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR901889A Expired FR2139M (enrdf_load_html_response) | 1962-06-25 | 1962-06-25 |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2139M (enrdf_load_html_response) |
-
1962
- 1962-06-25 FR FR901889A patent/FR2139M/fr not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bhakta et al. | Hepatoprotective activity of Cassia fistula leaf extract | |
EP0287488B1 (fr) | Médicament, produit diététique et produit d'hygiène sous la forme d'une composition pulvérulente obtenue par adsorption de principes actifs sur un sucre à dissolution rapide et procédé d'obtention de ladite composition | |
JP2000169384A (ja) | 血糖値上昇抑制乃至下降用組成物 | |
FR2680368A1 (fr) | Alpha-glycosyl-quercetine, son procede de preparation et ses utilisations. | |
FR2698791A1 (fr) | Nouveaux extraits de cucurbita sp., procédé pour leur préparation et médicaments et cosmétiques les contenant. | |
LU85973A1 (fr) | Utilisation therapeutique de gm1 dans des pathologies cerebrales severes dues a une ischemie | |
FR2581310A1 (fr) | Composition therapeutique comportant de l'acide a-linolenique et un compose susceptible de favoriser le passage de l'acide au travers de la membrane cellulaire et extrait de plantes comprenant l'acide et le compose | |
FR2460669A1 (fr) | Compositions pharmaceutiques a base de rifamycine sv et ses sels adaptes au traitement du rhumatisme articulaire et procede pour leur preparation | |
JP2010024208A (ja) | Ucp2発現亢進剤 | |
FR2139M (enrdf_load_html_response) | ||
CN1568929A (zh) | 含有腐植酸的化妆品及腐植酸在化妆品方面的应用 | |
FR2922110A1 (fr) | Utilisation d'un produit puissant extrait de rhizomes de zingiber officinale dans le traitement d'une maladie associee a helicobacter pylori | |
EP0342139B1 (fr) | Utilisation de l'Aspartate d'Arginine pour la fabrication d'un médicament pour traiter certains troubles de la mémoire | |
JP5086331B2 (ja) | 細菌性疾患、ウィルス性疾患、真菌症、炎症、及び疼痛の治療用組成物 | |
JP2727096B2 (ja) | 抗皮膚糸状菌剤 | |
KR960700064A (ko) | 아연이 보충된 전립선 추출물 | |
FR2507477A1 (fr) | Nouveau procede de preparation d'un extrait de feuilles d'olea europea riche en oleuropeine, produits obtenus, application a titre de medicaments et compositions les renfermant | |
FR2669823A1 (fr) | Extrait de melange d'ecorce de philodendron et de graines de croton, procede pour sa preparation et drogue contenant celui-ci. | |
JPS63316733A (ja) | 抗ウイルス剤 | |
JP2022187483A (ja) | オートファジー促進用組成物 | |
CN107753532A (zh) | 一种刺果番荔枝根提取物及其抗糖尿病用途 | |
JPS6150922A (ja) | 黄柏抽出成分含有皮膚外用剤 | |
JP2008508263A (ja) | 白頭翁根の抗腫瘍効果を向上させる方法及びその方法により調合した組成物 | |
CH630803A5 (en) | Medicinal preparations, for the treatment of hypercholesterolaemia in particular | |
FR2700268A1 (fr) | Composition cosmétique ou pharmaceutique, notamment dermatologique, contenant un extrait de Vismia. |